Molecular and cellular mechanisms of myocardial failure

American Journal of Cardiology

Volumn 80, Issue 11 A, 1997, Pages

  Colucci, Wilson S ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NORADRENALIN; VASODILATOR AGENT;

ANGIOTENSIN BLOOD LEVEL; CONFERENCE PAPER; HEART FUNCTION; HEART INFARCTION; HEART STRESS; HUMAN; NORADRENALIN BLOOD LEVEL; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0030663953     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00845-X     Document Type: Conference Paper

References (83)

1. Cohn JN. Structural basis for heart failure Ventricular remodeling and its pharmacological inhibition . Circulation. 91:1995;2504-2507.
2. Katz AM. The cardiomyopathy of overload an unnatural growth response in the hypertrophied heart . Ann Intern Med. 121:1994;363-371.
3. Anversa P, Ricci R, Olivetti G. Quantitative structural analysis of the myocardium during growth and induced cardiac hypertrophy a review . J Am Coll Cardiol. 7:1986;1140-1149.
4. 1 adrenergic response. J Clin Invest. 72:1983;732-738.
5. 1A adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J Biol Chem. 268:1993;15374-15380.
6. 1 receptor subtype . Circ Res. 73:1993;413-423.
7. Shubeita HE, McDonough PM, Harris AN, Knowlton KU, Glembotski CC, Brown JH, Chien KR. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes A paracrine mechanism for myocardial cell hypertrophy . J Biol Chem. 265:1990;20555-20562.
8. Thaik CM, Calderone A, Takahashi N, Colucci WS. Interlukin-1β modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest. 96:1995;1093-1099.
9. Sadoshima J-I, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II medicates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 75:1993;977-984.
10. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw B-A. Programmed myocyte death in end-stage heart failure. N Engl J Med. 335:1996;1182-1189.
11. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, DeLoreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P. Apoptosis in the failing human heart. N Engl J Med. 336:1997;1131-1141.
12. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki L-M. Apoptosis in human acute myocardial infarction. Circulation. 95:1997;320-323.
13. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 94:1994;1621-1628.
14. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, Anversa P. Apoptotic and necrotic myocyte cell death are independent contributing variables of infarct size in rats. Lab Invest. 74:1996;86-107.
15. Liu Y, Cigola E, Cheng W, Kajstura J, Olivetti G, Hintze TH, Anversa P. Myocyte nuclear mitotic division and programmed myocyte death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest. 73:1995;771-787.
16. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P. Stretch-induced programmed myocyte cell death. J Clin Invest. 96:1995;2247-2259.
17. Teiger E, Dam T-V, Richard L, Wisnewsky C, Tea B-S, Gaboury L, Tremblay J, Schwartz K, Hamet P. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest. 97:1996;2891-2897.
18. Colucci WS. Apoptosis in the heart. N Engl J Med. 335:1996;1224-1226.
19. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium Fibrosis and renin-angiotensin-aldosterone system . Circulation. 83:1991;1849-1865.
20. Conrad CH, Brooks WW, Hayes JA, Sen S, Robinson KG, Bing OHL. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation. 91:1995;161-170.
21. Calderone A, Takahashi N, Izzo NJ, Thaik CM, Colucci WS. Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs. Circulation. 92:1995;2385-2390.
22. Guarda E, Katwa LC, Myers PR, Tyagi SC, Weber KT. Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc Res. 27:1993;2130-2134.
23. Terracio L, Rubin K, Gullberg D, Balog E, Carver W, Tyring R, Borg TK. Expression of collagen binding integrins during cardiac development and hypertrophy. Circ Res. 68:1991;734-744.
24. Burgess ML, Carver WE, Terracio L, Wilson SP, Wilson MA, Borg TK. Integrin-mediated collagen gel contraction by cardiac fibroblasts. Circ Res. 74:1994;291-298.
25. Ikeda U, Ikeda M, Kano S, Shimada K. Neutrophil adherence to rat cardiac myocyte by proinflammatory cytokines. J Cardiovasc Pharmacol. 23:1994;647-652.
26. Takahashi T, Allen PD, Izumo S. Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles. Circ Res. 71:1992;9-17.
27. Arai M, Alpert NR, MacLennan DH, Barton P, Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure. Circ Res. 72:1993;463-469.
28. Wollert KC, Taga T, Saito M, Narazaki M, Kishimoto T, Glembotski CC, Vernallis AB, Heath JK, Pennica D, Wood WI, Chien KR. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy Assembly of sarcomeric units in series VIA gp 130/leukemia inhibitory factor receptor-dependent pathways . J Biol Chem. 271:1996;9535-9545.
29. Feldman AM, Weinberg EO, Ray PE, Lorell BH. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res. 73:1993;184-192.
30. Boluyt MO, O'Neill L, Meredith AL, Bing OHL, Brooks WW, Conrad CH, Crow MT, Lakatta EG. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Circ Res. 75:1994;23-32.
31. Beuckelmann DJ, Nabauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation. 85:1992;1046-1055.
32. 2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J Clin Invest. 90:1992;927-935.
33. Feldman AM, Ray PE, Silan CM, Mercer JA, Minobe W, Bristow MR. Selective gene expression in failing human heart Quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction . Circulation. 83:1991;1866-1872.
34. Brillantes A-M, Allen P, Takahashi T, Izumo S, Marks AR. Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy. Circ Res. 71:1992;18-26.
35. Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, McCune SA, Altschuld RA, Lederer WJ. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science. 276:1997;800-806.
36. Lowes BD, Minobe WA, Abraham WT, Roden RL, Port JD, Gilbert EM, Larrabee P, Bristow MR. Downregulation of α- and upregulation of β-myosin heavy chain in intact failing human ventricles. J Am Coll Cardiol 1997:in press.
37. Anderson PAW, Malouf NN, Oakeley AE, Pagani ED, Allen PD. Troponin T isoform expression in the normal and failing human left ventricle a correlation with myofibrillar ATPase activity . Basic Res Cardiol. 87:1992;117-127.
38. Bristow MR. Changes in myocardial and vascular receptors in heart failure. J Am Coll Cardiol. 22:1993;61A-71A.
39. Colucci WS, Denniss AR, Leatherman GR, Quigg RJ, Ludmer PL, Marsh JD, Gauthier DF. Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition . J Clin Invest. 81:1988;1103-1110.
40. Bristow MR. Mechanisms of action of β-blocking agents in heart failure. Am J Cardiol. 80:(suppl):1997;26L-40L.
41. Sadoshima J-I, Jahn L, Takahashi T, Kulik TJ, Izumo S. Molecular characterizations of the stretch-induced adaptation of cultured cardiac cells An in vitro model of load-induced cardiac hypertrophy . J Biol Chem. 267:1992;10551-10560.
42. 1 expression in rat ventricular myocytes. J Clin Invest. 94:1994;1470-1483.
43. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Hiroi Y, Mizuno T, Maemura K, Kurihara H, Aikawa R, Takano H, Yazaki Y. Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J Biol Chem. 271:1996;3221-3227.
44. Clark WA, Rudnick SJ, LaPres JJ, Andersen LC, LaPointe MC. Regulation of hypertrophy and atrophy in cultured adult heart cells. Circ Res. 73:1993;1163-1176.
45. Geng YJ, Ishikawa Y, Vatner DE, Wagner TE, Bishop SP, Vatner SF, Homcy CJ. Overexpression of Gsα accelerates programmed cell death (apoptosis) of cardiomyocytes in transgenic mice. (Abstr.). Circulation. 94:(suppl 1):1996;1640.
46. Mann DL, Kent RL, Parsons B, Cooper G. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 85:1992;790-804.
47. Calderone A, Thaik CM, Takahashi N, Colucci WS. Norepinephrine-stimulated DNA and protein synthesis in cardiac fibroblasts are inhibited by nitric oxide and atrial naturetic factor. (Abstr.). Circulation. 92:(suppl I):1995;I-382.
48. Kajstura J, Cigola E, Malhotra A, Li P, Cheng W, Meggs L, Anversa P. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Cell Cardiol. 29:1997;859-870.
49. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res. 69:1991;475-482.
50. Lindpaintner K, Lu W, Niedermajer N, Schieffer B, Just H, Ganten D, Drexler H. Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. J Mol Cell Cardiol. 5:1993;133-143.
51. Meggs LG, Coupet J, Huang H, Cheng W, Li P, Capasso JM, Homcy CJ, Anversa P. Regulation of angiotensin II receptors on ventricular myocytes after myocardial infarction in rats. Circ Res. 72:1993;1149-1162.
52. Sakai S, Miyauchi T, Sakurai T, Kasuya Y, Ihara M, Yamaguchi I, Goto K, Sugishita Y. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure marked increase in endothelin-1 production in the failing heart . Circulation. 93:1996;1214-1222.
53. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Letters to Nature. 384:1996;353-355.
54. Colucci WS. Myocardial endothelin Does it play a role in myocardial failure? Circulation. 93:1996;1069-1072.
55. Parker TG, Packer SE, Schneider MD. Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. J Clin Invest. 85:1990;507-514.
56. Casscells W, Bazoberry F, Speir E, Thompson N, Flanders K, Kondaiah P, Ferrans VJ, Epstein SE, Sporn M. Transforming growth factor-1 in normal heart and in myocardial infarction. Ann NY Acad Sci. 593:1990;148-160.
57. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 223:1990;236-241.
58. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann D. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction a report from the studies of left ventricular dysfunction (SOLVD) . J Am Coll Cardiol. 27:1996;1201-1206.
59. Meier B, Radeke HH, Selle S, Younes M, Sies H, Resch K, Habermehl GG. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha. Biochem J. 263:1989;539-545.
60. Webster KA, Discher DJ, Bishopric NH. Regulation of Fos and jun immediate-early genes by redox or metabolic stress in cardiac myocytes. Circ Res. 74:1994;679-686.
61. Murrell AC, Francis M, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J. 265:1990;659-665.
62. Pennisi E. Superoxides relay Ras protein's oncogenic message. Science. 275:1997;1567-1568.
63. Lander HM, Ogiste JS, Teng KK, Novogrodsky A. p21 ras as a common signaling target of reactive free radicals and cellular redox stress. J Biol Chem. 270:1995;21195-21198.
64. Dhalla AK, Singal PK. Antioxidant changes in hypertrophied and failing guinea pig hearts. Am J Physiol. 266:1994;H1280-H1285.
65. Dhalla AK, Hill MF, Singal PK. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol. 28:1996;506-514.
66. Feuerstein GZ, Bril A, Ruffolo RR Jr. Pharmacology of β blockers protective effects of carvedilol in the myocardium . Am J Cardiol. 80:(suppl):1997;41L-45L.
67. Feuerstein GZ, Yue TL, Cheng HY, Ruffolo RR. Myocardial protection by the novel vasodilating beta-blocker, carvedilol potential relevance of anti-oxidant activity . J Hypertens. 11:1993;541-548.
68. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. 93:1996;704-711.
69. Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, Glembotski CC, Quintana PJE, Sabbadini RA. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes Involvement of the sphingolipid signaling cascade in cardiac cell death . J Clin Invest. 98:1996;2854-2865.
70. Youker K, Smith CW, Anderson DC, Miller D, Michael LH, Rossen RD, Entman ML. Neutrophil adherence to isolated adult cardiac myocytes. J Clin Invest. 89:1992;602-609.
71. Ikeda U, Ikeda M, Kano S, Shimada K. Neutrophil adherence to rat cardiac myocyte by proinflammatory cytokines. J Cardiovasc Pharmacol. 23:1994;647-652.
72. DeBelder AJ, Radomski MW, Why JF, Richardson PJ, Martin JF. Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease. Br Heart J. 74:1995;426-430.
73. Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, McKenna WJ, Fowler MB. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 93:1996;1087-1094.
74. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol. 105:1992;575-580.
75. Balligand J-L, Ungureanu-Longrois D, Simmons WW, Pimental D, Malinski TA, Kapturczak M, Taha Z, Lowenstein C, Davidoff AJ, Kelly RA, Smith TW, Michel T. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro . J Biol Chem. 269:1994;27580-27588.
76. Hare JM, Colucci WS. Role of nitric oxide in the regulation of myocardial function. Prog Cardiovasc Dis. 38:1995;155-166.
77. Balligand J-L, Ungureanu D, Kelly RA, Kobzik L, Pimental D, Michel T, Smith TW. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest. 91:1993;2314-2319.
78. Brady AJB, Poole-Wilson PA, Harding SE, Warren JB. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol. 263:1992;H1963-H1966.
79. Hare JM, Loh E, Creager MA, Colucci WS. Nitric oxide inhibits the contractile response to β-adrenergic stimulation in humans with left ventricular dysfunction. Circulation. 92:1995;2198-2203.
80. Yamamoto S, Tsusui H, Tagawa H, Saito K, Takahashi M, Tada H, Yamamoto M, Katoh M, Egashira K, Takeshita A. Role of myocyte nitric oxide in β-adrenergic hyporesponsiveness in heart failure. Circulation. 95:1997;1111-1114.
81. Pinsky DJ, Cai B, Yang X, Rodriguez C, Sciacca RR, Cannon PJ. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta. J Clin Invest. 95:1995;677-685.
82. Fukuo K, Hata T, Suhara T, Nakahashi T, Shinto Y, Tsujimoto Y, Morimoto S, Ogihara T. Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension. 27:1996;823-826.
83. Wu C-F, Bishopric NH, Pratt RE. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J Biol Chem. 272:1997;14860-14866.